<?xml version="1.0" encoding="UTF-8"?>
<p> The early intracellular VACV protein A35 was shown to inhibit presentation of viral antigens by the major histocompatibility complex of class II [
 <xref rid="R54" ref-type="bibr">54</xref>, 
 <xref rid="R55" ref-type="bibr">55</xref>]. Removal of the 
 <italic>A35R </italic>gene increases the production of virus-specific antibodies and enhances the protectiveness of VACV [
 <xref rid="R51" ref-type="bibr">51</xref>, 
 <xref rid="R52" ref-type="bibr">52</xref>]. 
</p>
